GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » COGS-to-Revenue

Sipai Health Technology Co (HKSE:00314) COGS-to-Revenue : 0.91 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co COGS-to-Revenue?

Sipai Health Technology Co's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$2,272 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$2,487 Mil.

Sipai Health Technology Co's COGS to Revenue for the six months ended in Dec. 2023 was 0.91.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sipai Health Technology Co's Gross Margin % for the six months ended in Dec. 2023 was 8.65%.

Sipai Health Technology Co COGS-to-Revenue Historical Data

The historical data trend for Sipai Health Technology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co COGS-to-Revenue Chart

Sipai Health Technology Co Annual Data
Trend Dec21 Dec22 Dec23
COGS-to-Revenue
0.92 0.92 0.91

Sipai Health Technology Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue - 0.91 0.93 0.91 0.91

Sipai Health Technology Co COGS-to-Revenue Calculation

Sipai Health Technology Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4700.415 / 5154.003
=0.91

Sipai Health Technology Co's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2272.372 / 2487.418
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sipai Health Technology Co  (HKSE:00314) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sipai Health Technology Co's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 2272.372 / 2487.418
=8.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sipai Health Technology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sipai Health Technology Co (HKSE:00314) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » COGS-to-Revenue
Comparable Companies
HKSE:02192 HKSE:09955 HKSE:01931 HKSE:02289 HKSE:00673 HKSE:06833 HKSE:00718 HKSE:08372 HKSE:00401 MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784
Traded in Other Exchanges
AX1:Germany
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Website
https://www.medbankshealthtech.com
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
Executives
Chang Jimmy Ching-hsin 2201 Interest of corporation controlled by you
Jeneration Group Limited 2201 Interest of corporation controlled by you
Leung Catherine Ho Yan 2202 Interest of your spouse
Purple Panther 2201 Interest of corporation controlled by you
Ma Xuguang 2501 Other
Li Ji 2501 Other
Wise Approach Investments Limited 2101 Beneficial owner
Ark Trust (hong Kong) Limited 2301 Trustee
Jpmorgan Chase & Co. 2502 Approved lending agent
Lucky Seven Healthcare Co., Ltd. 2101 Beneficial owner
Simul International Holdings Limited 2201 Interest of corporation controlled by you
Oriental Power Holdings Limited
Nasturtium Investment Limited
Tencent Mobility Limited
Tencent Holdings Limited

Sipai Health Technology Co (HKSE:00314) Headlines

No Headlines